Tracking periodontal treatment via salivary EVs: five key points

Have you ever wondered what’s happening deep in your gums after tartar is removed? Periodontal disease occurs when the balance between the mouth’s bacterial communities (biofilm) and the body’s defense system (immunity) breaks down, damaging the tissues and bone that support the teeth. The first-line basic treatment is non-surgical periodontal therapy (NSPT), which removes plaque and calculus under the gums using ultrasonic devices and hand instruments.

Recently, great attention has been paid to “extracellular vesicles (EVs)” in saliva—tiny, nanosized sacs. EVs are like “message-carrying parcels” released by cells that protect and transport information such as proteins and small RNAs. By examining EVs, we can track what’s happening in the body using a minimally invasive approach.

In one study (25 people with severe periodontitis; sampled before treatment, at 3 months, and at 6 months), researchers separated and analyzed EVs derived from human cells and those released by bacteria and fungi. As a result, they could see the course of healing in greater detail than before. Here are five easy-to-understand takeaways.

Looking at EVs shows clearer changes than looking at “whole saliva” alone

When you analyze whole saliva as-is, food debris and enzymes can blur important signals.
EVs, on the other hand, have lipid membranes that protect their contents, so key information (proteins and nucleic acids) is less likely to degrade, making time-course changes easier to detect.
In fact, treatment-related differences were hard to spot in whole-saliva analyses, but became clear when examining the contents of EVs.
Takeaway: To monitor treatment effects with minimal discomfort, targeting EVs appears more promising.

The body shifts from an “inflammation mode” to a “repair mode”

Looking at cytokines (immune-regulating molecules) within human-derived EVs, IL-4 and IL-9—associated with repair and calmer responses—increased at 6 months. IL-12 (with a “sentinel-like” role) was also appropriately maintained.
This suggests that as treatment progresses, the body moves not only to suppress strong inflammation but also toward “repairing damaged areas and rebalancing.”
Takeaway: Over time, immune activity may settle and shift into a mode that supports tissue recovery.

“Messaging (vesicles)” among pathogenic bacteria decreases

Periodontal bacteria use tiny particles called BEVs (bacterial extracellular vesicles) to exchange toxins and information.
After treatment, these BEVs tended to decrease overall. Notably, reductions in BEVs linked to well-known periodontal pathogens (e.g., Porphyromonas gingivalis, Tannerella forsythia) were associated with improvements in pocket depth and bleeding.
Takeaway: It’s not just that bacterial counts go down—the “connections” and “offensive strategies” among bacteria may weaken.

Even as bacterial counts drop, vesicles carrying LPS can increase

In some cases, outer-membrane vesicles containing LPS (lipopolysaccharide), a component of Gram-negative bacteria, increased at 6 months.
This may occur because the oral microbial community changes how and what it releases in response to the environment, even if specific pathogens decline.
Takeaway: A drop in particular species does not always mirror the total amount of vesicles the community releases. Treatment effects should be viewed in terms of the whole microbial ecosystem.

Not only bacteria—fungi also change over time

Fungi are also present in the mouth, and they release EVs as well.
While bacterial BEVs tended to stabilize by 3 months, shifts in fungal EVs took about 6 months to become statistically evident.
Specifically, EVs linked to inflammatory activity decreased, while EVs from fungi that commonly inhabit healthy mouths increased—indicating a community turnover.
Takeaway: Treatment effects extend beyond bacteria to the entire oral ecosystem, including fungi, moving toward a calmer balance over time.

Summary

Over a 6‑month follow-up, we see a pattern in which “bacterial cross-talk weakens,” “immunity tilts toward repair,” and “the broader ecosystem—including fungi—gradually rebalances.”
In particular, analyzing EVs in saliva may help track treatment progress without strongly irritating the gums.
Although still in the research phase, saliva-based EV testing could someday let us quantify healing status in the mouth. It’s a low-discomfort approach with promise for monitoring recovery.

Reference

Liu, C., Wang, J., Lai, A., Salomon, C., Seneviratne, C. J., Ivanovski, S., & Han, P. (2026). An Exploratory Longitudinal Analysis of Salivary Host, Bacterial and Fungal Extracellular Vesicles Following 6‐Month Non‐Surgical Periodontal Therapy in Periodontitis. Journal of Clinical Periodontology.

Ask question/ Send the Email to Mr. Root canal, Dr. Miyashita

Make an appointment for consultation today.

Tokyo International Dental Clinic Roppongi

Here is the MAP